Faster clarification of acute heart attacks at the Emergency Department (Legevakten) in Oslo (OUT-ACS-studien)
Improving the safety of oral anticoagulants
The BETAMI trial (national trial on the use of beta blockers in myocardial infarction)
Detecting changes in cardiac extracellular matrix – identification of novel biomarkers
Quality of care and outcome in acute myocardial infarction - A population-based study
Heart failure in Norway – a registry-based approach
The role of genetic factors in acute myocardial infarction
Use of Music therapy in Cardiac Implantable Electronic Device (CIED) lead extractions
Hyperemesis gravidarum and cardiovascular disease
Involved in SMINC (MINOCA Myocardial Infarction with Non-Obstructrive Coronary Arteries), EXHAUSTION (Exposure to heat and air pollution in Europe – cardiopulmonary impacts and benefits of mitigation and adaptation), PSARA (Inflammatory Disease Activity, and Bone and Cartilage Markers in Rheumatic Patients, and the PROG-IMT
Haukeland-Parker S, Jervan Ø, Ghanima W, Spruit MA, Holst R, Gleditsch J, Tavoly M, Stavem K, Steine K, Atar D, Dahm AEA, Klok FA, Johannessen HH(2025) Exercise capacity, dyspnea, and quality of life 6 months after exercise-based rehabilitation in patients with persistent dyspnea following pulmonary embolism Res Pract Thromb Haemost, 9(2), 102736 DOI 10.1016/j.rpth.2025.102736, PubMed 40242191
Vranckx P, Halvorsen S(2025) Cracking the clot: the RIVAWAR trial challenges warfarin's reign in left ventricular thrombus post-acute coronary syndrome Eur Heart J Acute Cardiovasc Care, 14(4), 243-244 DOI 10.1093/ehjacc/zuaf052, PubMed 40171935
Atar D, Vandenbriele C, Agewall S, Gigante B, Goette A, Gorog DA, Holme PA, Krychtiuk KA, Rocca B, Siller-Matula JM, Valgimigli M, Rubboli A, Klamroth R(2025) Management of patients with congenital bleeding disorders and cardiac indications for antithrombotic therapy Eur Heart J Cardiovasc Pharmacother(in press) DOI 10.1093/ehjcvp/pvaf006, PubMed 40145128
